secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001193125-25-084340
Event type: other
Sentiment:  negative
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rein Therapeutics auditor Marcum resigns, CBIZ appointed; going concern noted
-----------------------------------------------------------------------------

- Marcum LLP resigned as independent auditor on April 16, 2025; CBIZ CPAs P.C. engaged by Audit Committee.
- Marcum's reports for 2024 and 2023 included a going concern explanatory paragraph for Rein Therapeutics.
- No disagreements on accounting principles or practices between Marcum and the company.
- Material weaknesses in internal controls over financial reporting were reported for both 2024 and 2023.
- Company authorized Marcum to fully respond to successor auditor inquiries.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525084340/0001193125-25-084340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525084340/d940643d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-084340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer